Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.

@article{Goldstein2005AcetaminophenAA,
  title={Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.},
  author={Jerome Goldstein and Stephen David Silberstein and Joel R. Saper and Arthur H Elkind and Timothy R. S. Smith and R Michael Gallagher and J P Battikha and Howard Hoffman and Jeffrey S. Baggish},
  journal={Headache},
  year={2005},
  volume={45 8},
  pages={973-82}
}
OBJECTIVE To address the need for a rigorous, direct comparison of prescription and over-the-counter (OTC) migraine drugs and to expand the database on early treatment of migraine. BACKGROUND Most people who experience migraine use OTC medications to treat their symptoms, but no head-to-head clinical trials comparing these agents with prescription migraine therapies have been published. In addition, even though most migraineurs treat early in the attack, few studies have been conducted to… CONTINUE READING